Results 1 to 10 of about 130,730 (348)

Proton pump inhibitors and gastroenteritis [PDF]

European Journal of Epidemiology, 2016
An association between proton pump inhibitor (PPI) therapy and bacterial gastroenteritis has been suggested as well as contradicted. The aim of this study was to examine the association between the use of PPIs and occurrence of bacterial gastroenteritis ...
de Visser, H. (Herman), Hassing, R.J. (Robert), Hofman, A. (Albert), Stricker, B.H.Ch. (Bruno), Verbon, A. (Annelies)   +4 more
core   +10 more sources

Proton-pump inhibitors and risk of renal disease [PDF]

Journal of Nephropharmacology, 2017
Proton pump inhibitors (PPIs) are one group of drugs that inhibit gastric acid secretion by binding irreversibly to the gastric proton pump to the gastric proton pump.
Mahrang Hedaiaty, Mohammad Reza Tamadon, Armin Amiri, Leila Mahmoodnia   +3 more
doaj   +4 more sources

Hypocalcemia After Thyroidectomy in Patients Taking Proton Pump Inhibitors [PDF]

Laryngoscope Investigative Otolaryngology
Objective Calcium homeostasis is regulated by the effects of parathyroid hormone (PTH) and vitamin D on the bones, GI tract, and kidneys. Post‐thyroidectomy hypoparathyroidism and resultant hypocalcemia are common complications associated with prolonged ...
Maxwell Rossip, F. Jeffrey Lorenz, Neerav Goyal, David Goldenberg   +3 more
doaj   +2 more sources

Proton-pump inhibitors

South African Family Practice, 2015
Proton-pump inhibitors (PPIs) are a class of drugs that profoundly suppress gastric acid secretion, and thus have become the treatment of choice for gastro-oesophageal reflux disease and peptic ulcer disease. PPIs are considered safe and effective. It is
Vasudevan G. Naidoo
doaj   +4 more sources

Deprescribing proton pump inhibitors

Singapore Medical Journal, 2023
Kim Jun Kevin Teh, Hai Kiat Troy Puar, Choon How How, Teck Kiang Malcolm Tan   +3 more
doaj   +3 more sources

Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. [PDF]

, 2012
Introduction Emerging epidemiological evidence suggests that proton pump inhibitor (PPI) acid-suppression therapy is associated with an increased risk of Clostridium difficile infection (CDI).
A Deshpande, A Liberati, A Niklasson, Abdur Rahman Khan, Abed AlLehibi, Alex J. Sutton, Aref A. Bin Abdulhak, AZ Mat Saad, BT Batuwitage, C Bavishi, C Cahir, CM Wilcox, CS Eom, CS Kwok, D Ahrens, DF Stroup, DL Bhatt, DO Lowe, F Sierra, Faisal A. Alasmari, GH Guyatt, Imad M. Tleyjeh, J Johnstone, J Leonard, J Theisen, J Thorens, J Zhang, JL Peters, JM Boyce, JS Bajaj, KH Wilson, Larry M. Baddour, LC McDonald, LK Archibald, M Charlot, M Egger, Markus M. Heimesaat, MD Howell, MD Redelings, MM Nerandzic, Mohamad Al Tannir, Muhammad Riaz, Musa A. Garbati, Mushabab AlGhamdi, Patricia J. Erwin, PK Kutty, PS Yachimski, R DerSimonian, R Scagliarini, RL Jump, S Dial, S Janarthanan, S Jayatilaka, S Linney, S Schneeweiss, SG Moreno, SG Moreno, Talal Ibrahim, WR Jarvis   +58 more
core   +10 more sources

Multimorbidities and Overprescription of Proton Pump Inhibitors in Older Patients. [PDF]

PLoS ONE, 2015
To determine whether there is an association between overprescription of proton pump inhibitors (PPIs) and multimorbidities in older patients.Multicenter prospective study.Acute geriatric medicine at the University Hospital of Nantes and the Hospital of ...
Anne Delcher, Sylvie Hily, Anne Sophie Boureau, Guillaume Chapelet, Gilles Berrut, Laure de Decker   +5 more
doaj   +1 more source

The influence of proton pump inhibitors on tissue attachment around teeth and dental implants: A scoping review

Clinical and Experimental Dental Research, 2022
Objectives Proton pump inhibitors, such as omeprazole and pantoprazole, are frequently prescribed for the treatment of acid reflux. However, those medications have been shown to affect a variety of physiologic processes, including bone homeostasis and ...
Bhavneet K. Chawla, Robert E. Cohen, Elizabeth M. Stellrecht, Lisa M. Yerke   +3 more
doaj   +1 more source

Electroencephalography Signatures for Hepatic Encephalopathy in Cirrhosis Patients Treated with Proton Pump Inhibitors: An Exploratory Pilot Study

Biomedicines, 2022
(1) Background: Hepatic encephalopathy (HE) is a common complication in cirrhosis patients, and recently, clinical evidence indicates that a higher risk of HE is associated with the usage of proton pump inhibitors.
Pan Zhang, Lizhi Zhou, Li Chen, Zhen Zhang, Rui Han, Gangwen Guo, Haocheng Zhou   +6 more
doaj   +1 more source

Clinical effects of proton pump inhibitors: Focus on pharmacogenetics, kinetics and dynamics [PDF]

, 2010
This thesis describes the clinical effects of proton pump inhibitors, with focus on pharmacogenetics, kinetics and dynamics. The aims were to investigate the occurence of Rebound Acid Hypersecretion and to investigate the speed of onset, the duration of ...
Hunfeld, N.G.M. (Nicole)
core   +6 more sources